Showing results (41-50 of 1,683) with videos related to
Sort By:
Pageof 169
Psychopharmacology|January 1, 1992
PET analysis of alcohol interaction with the brain disposition of [11C]flumazenilS Pauli, S Liljequist, L Farde, et al.International Journal of Radiation Applications and Instrumentation. Part A, Applied Radiation and Isotopes|January 1, 1986
Preparation of 11C-labelled SCH 23390 for the in vivo study of dopamine D-1 receptors using positron emission tomographyC Halldin, S Stone-Elander, L Farde, et al.Journal of Neuroscience Methods|January 1, 1991
Autoradiography with saturation experiments of 11C-Ro 15-1788 binding to human brain sectionsA Persson, R d'Argy, P G Gillberg, et al.European Journal of Pharmacology|August 16, 1991
Synthesis and binding properties of the fluorinated substituted benzamide [3H]NCQ 115, a new selective dopamine D2 receptor ligandH Hall, T Högberg, C Halldin, et al.Journal of Neurochemistry|December 1, 1990
Comparison of the in vitro receptor binding properties of N-[3H]methylspiperone and [3H]raclopride to rat and human brain membranesH Hall, I Wedel, C Halldin, et al.Brain : a Journal of Neurology|March 1, 1997
PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's diseaseN Ginovart, A Lundin, L Farde, et al.Neuroscience|January 1, 1992
Effect of raclopride on dopamine D2 receptor mRNA expression in rat brainJ Kopp, N Lindefors, S Brené, et al.Psychopharmacology|January 1, 1993
PET examination of [11C]NNC 687 and [11C]NNC 756 as new radioligands for the D1-dopamine receptorP Karlsson, L Farde, C Halldin, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 29, 1998
Carbon-11-NNC 112: a radioligand for PET examination of striatal and neocortical D1-dopamine receptorsC Halldin, C Foged, Y H Chou, et al.Psychopharmacology Series|January 1, 1988
PET scanning--a new tool in clinical psychopharmacologyG Sedvall, L Farde, H Hall, et al.Pageof 169